Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies-Reference-Cited by-同舟云学术

Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies

Published:2016-12 Issue:6 Volume:38 Page:777-786
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Tippin Timothy K.,Morrison Marion E.,Brundage Thomas M.,Momméja-Marin Hervé

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1;Cihlar;Mol Pharmacol.,1999

2. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs;Cihlar;Nucleosides Nucleotides Nucleic Acids.,2001

3. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1;Ho;J Am Soc Nephrol.,2000

4. Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys;Lacy;Toxicol Sci.,1998

5. Organic anion transporter (Slc22a) family members as mediators of toxicity;Sweet;Toxicol Appl Pharmacol.,2005

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate;Clinical Pharmacology in Drug Development;2024-01-03

2. The Potential Relationship Between Cardiovascular Diseases and Monkeypox;Current Problems in Cardiology;2024-01

3. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates;Chemical Society Reviews;2024

4. Mpox: Diagnosis and Management for the Inpatient Dermatologist;Current Dermatology Reports;2023-12-12

5. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20